ID 12/26 Consultation Paper on Capital Treatment for Securitisation and Infrastructure Investments for Insurers
AI Analysis
MAS has opened consultation P018-2026 on further refinements to the RBC 2 capital treatment of securitisation and infrastructure investments, following revisions that took effect on 31 March 2026. The proposals would make capital charges more risk-sensitive by extending potential relief to qualifying rated infrastructure debt, risk-mitigated infrastructure investments and certain senior investment-grade securitisation tranches, while supporting insurer capability-building through a separate S$30 million grant scheme.
Key dates
- 2026-11-02
- MAS published Circular ID 12/26 and opened consultation P018-2026 on capital treatment for securitisation and infrastructure investments under RBC 2.
- 2026-11-02
- The S$30 million Infrastructure Capability Development Grant for Insurers took effect, subject to MAS grant arrangements.
- 2026-12-18 Deadline
- Deadline for submitting comments on consultation P018-2026.
- 2026-03-31
- Earlier finalised RBC 2 revisions to the capital treatment of securitisation and infrastructure investments took effect; the current consultation proposes further refinements to that framework.
Suggested considerations
- Compliance and capital teams should review the consultation paper and consider submitting comments to MAS by 18 December 2026, particularly on eligibility tests, evidence requirements, capital calibrations and implementation timing.
- Firms should map current and planned infrastructure debt, infrastructure equity, infrastructure-fund and securitisation exposures against the proposed qualifying criteria, distinguishing assets that could benefit from lower charges from assets that would remain subject to existing treatment.
- Investment, risk and finance functions should assess whether existing due diligence, valuation, credit assessment, look-through analysis and documentation can evidence contractual revenues, demand-risk limitations, counterparty strength, tranche seniority, investment grade status, diversification, liquidity and simplicity, transparency and comparability.
- Firms should monitor amendments to MAS Notice 133 and Notice FHC-N133 and avoid reflecting proposed capital relief in regulatory capital planning, pricing or investment limits until the proposals are finalised and effective.
- Insurers may wish to assess whether they qualify for or could benefit from the Infrastructure Capability Development Grant and identify capability gaps in origination, underwriting, infrastructure valuation, credit analysis and ongoing monitoring.
- Governance teams should establish a process for monitoring the additional external credit assessment institutions, standardised disclosure templates, fund-manager declarations and assessment guidance that MAS may introduce.
- Groups with infrastructure investments held through funds or structured products should confirm whether the final treatment will permit look-through and should not assume that infrastructure-backed structured products qualify for infrastructure treatment rather than structured-product treatment.
What changed
This is a consultation and does not itself amend Notice 133 or impose new binding capital requirements. MAS is proposing lower capital charges for rated infrastructure debt that satisfies specified credit-quality and other qualifying criteria; for qualifying infrastructure equity and debt investments with risk mitigants such as long-term contractual or regulated revenues, limited demand-risk exposure and strong counterparties; and for senior investment-grade securitisation tranches meeting relevant simplicity, transparency and comparability criteria or specified diversification and liquidity safeguards. MAS also intends to recognise additional external credit assessment institutions with relevant infrastructure and securitisation expertise and is developing standardised disclosure template
Compliance impact
The publication has no immediate effect on binding capital calculations, but it is strategically significant for insurers because final measures could change risk-weighted capital requirements, asset allocation economics, investment limits and eligibility controls for infrastructure and securitised assets. Market commentary characterises the initiative as a targeted easing for qualifying assets in
Who is affected
Related regulations
References
AI-generated analysis. May contain errors or omissions — verify with the original MAS source before acting. Full disclaimer.
What the MAS said
Informs insurers on the issuance of the Consultation Paper on Capital Treatment for Securitisation and Infrastructure Investments for Insurers.
Published by MAS . Read the full notice at the source for the authoritative text.